Shift Bioscience
PrivateLast Round
Seed
Oct 15, 2024
Total Funding Raised
$18M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Shift Bioscience operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Seed round in October 2024.
Shift Bioscience is a biotechnology company that develops cell rejuvenation therapies for age-related diseases using an AI-driven cell simulation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shift Bioscience Comparables
Compare Shift Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clock.bio | 91% | |
| Rejuvenation Technologies | 85% | |
| Clock Health | 84% |
For institutional investors. Book with your work email.
Shift Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 15, 2024 | ||||
| Pre Seed | Jul 21, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Shift Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BGF | Seed |
| F-Prime Capital | Seed |
| Kindred Capital | Pre Seed, Seed |
| F-Prime Capital | Pre Seed, Seed |
| Healthspan Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 109% MoM.
- Jun 13, 2025
Developing a platform to identify cell-rejuvenating transcription factor combinations.
For institutional investors. Book with your work email.
Shift Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shift Bioscience's valuation, stock price, and market status.
Is Shift Bioscience a public or private company?
Shift Bioscience is a private company.
What is the current stock price of Shift Bioscience?
Shift Bioscience is a private company, so its shares have no public market price. Caplight tracks Shift Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shift Bioscience worth (valuation)?
Valuation information for Shift Bioscience is not publicly available.
Can I buy Shift Bioscience stock?
Shift Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shift Bioscience's last funding round?
Shift Bioscience's most recent funding round was Seed on October 15, 2024.
Who are the main investors in Shift Bioscience?
Key investors in Shift Bioscience include BGF.
Will Shift Bioscience IPO soon?
No public IPO plans have been announced for Shift Bioscience.
How can I track Shift Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Shift Bioscience's shares on secondary markets.